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Refractory angina pectoris is defined as angina refractory to optimal medical treatment and standard coronary 
revascularization procedures. Despite recent therapeutic advances, patients with refractory angina pectoris are 
not adequately treated. Spinal cord stimulation is a minimally invasive and reversible technique which utilizes 
electrical neuromodulation by means of an electrode implanted in the epidural space. It has been reported 
to be an effective and safe treatment for refractory angina pectoris. We report a case of spinal cord stimulation 
which has effectively relieved chest pain due to coronary artery disease in a 40-year-old man. This is the first 
report of spinal cord stimulation for treatment of refractory angina pectoris in South Korea. (Korean J Pain 
2012;  25:  121-125)
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As the development of coronary revascularization and 
medication management have led to an improved survival 
rate following coronary events in the last few decades, it 
seems likely that the number of patients who remain se-
verely disabled due to refractory angina will increase. 
Refractory angina pectoris is a chronic condition char-
acterized by the presence of severe chest pain, caused by 
coronary artery disease (CAD), which cannot be relieved 
by coronary intervention, coronary artery bypass grafting, 
and optimal medical treatment [1]. This limits the physical 
activity of patients and leads to more frequent hospital 
admissions. Spinal cord stimulation (SCS) is an electrical 
neuromodulation therapy, and it appears to be an effective 
and safe treatment option for this specific group of pa-
tients [2-7]. 
This is the first report of spinal cord stimulation used 
to treat angina pectoris in South Korea.
CASE  REPORT
A 40-year-old man was admitted to the emergency 
departmen t d ue to se v ere chest pain. He com plained of 
persistent tightness in the left anterior chest. An emergent 
coronary angiogram (CAG) revealed total occlusion of the 
proximal left anterior descending coronary artery (LAD). 
Percutaneous coronary intervention with stent implantation 122 Korean J Pain Vol. 25, No. 2, 2012
www.epain.org
Fig. 1. Coronary angiogram 
(CAG) before and after 
percutaneous coronary inter-
vention (PCI). (A) CAG 
shows total occlusion of the 
proximal left anterior descen-
ding coronary artery. (B) 
After the PCI, successful re-
perfusion was obtained. 
in the LAD successfully restored coronary blood flow and 
completely relieved his chest pain (Fig. 1). Five days later, 
the patient began to complain of left anterior chest dis-
comfort, which gradually worsened over the next two weeks. 
A l t h o u g h  t h e  c a r d i o l o g i s t s  a g a i n  p e r f o r m e d  a  d e t a i l e d  
evaluation of cardiac function, there were no changes in 
the electrocardiogram and cardiac enzymes and no in-stent 
restenosis or de novo lesions seen on the CAG. Over the 
next year, the patient visited the emergency department 
and admitted several times due to his relentless chest pain, 
t h u s  t h e  t o t a l  d a y s  o f  h o s p i t a l i z a t i o n  w a s  a b o u t  h a l f  a 
year. Multiple cardiac evaluations were performed to eluci-
date the cause of the angina. Another stent was implanted 
in the obtuse marginal branch of the left circumflex artery 
for  intermediate  stenosis.  Ergonovine-induced  spasm  in 
the right coronary artery was detected on another angiog-
r a p h y ,  a n d  t h e  c a r d i o l o g i s t s  a d d e d  a  c a l c i u m  c h a n n e l  
blocker to the patient’s medications. However, these addi-
tional interventions did not improve his symptoms. Adequate 
results could not be obtained on an exercise electrocardio-
gram, due to the patient’s poor exercise tolerance. Echo-
cardiography showed persistent ischemic cardiomyopathy 
w i t h  m o d e r a t e  l e f t  v e n t r i c u l a r  d y s f u n c t i o n .  A  f o l l o w - u p  
coronary angiogram showed patent previously stented ar-
teries and no significant stenosis in other arteries. 
When the patient was referred to the pain clinic, he 
was experiencing paroxysmal deep anterior chest pain 2 
or 3 times a day. The pain was of a squeezing and pressing 
nature, 7 to 8 on a numeric rating scale (NRS, 0 = no pain, 
10 = maximum pain), and was not relieved by sublingual 
nitroglycerine. For several months, while the patient was 
prescribed oral morphine 90 mg, gabapentin 1,800 mg, 
and nortriptyline 20 mg per day, we tried various proce-
dures to control his pain, such as stellate ganglion block, 
percutaneous thoracic sympathetic neurotomy using ther-
mal radiofrequency, epidural morphine injection, and intra-
venous ketamine infusion. These techniques all had only 
temporary efficacy. Finally, despite a continuous epidural 
infusion of morphine, his paroxysmal angina was worsen-
ing, rising to 8 to 9 on the NRS.
After careful discussion with the patient and his fam-
ily, they agreed to a trial of SCS. The patient was taken 
to the operating room, monitored, and placed in the prone 
position. Anesthesia was accomplished by local anesthetic 
infiltration. A 15-gauge Tuohy needle was inserted in the 
T4-5 interlaminar space under fluoroscopic guidance. The 
epidural space was identified using a loss-of-resistance 
technique. An Octad lead 3778 (Medtronic Inc., Minneapolis, 
Minnesota, USA) was inserted through the needle and ad-
vanced under fluoroscopic guidance until the tip lay at the 
C7-T1 intervertebral disc level (Fig. 2). The stimulation pa-
rameters were pulse width of 270 μs, amplitude of 2.0 mA, 
and frequency of 50 Hz. During the 10 days of trial stim-
ulation, the intensity and frequency of the patient’s chest 
pain was reduced by 60-70% without epidural infusion 
of  morphine.  Therefore,  a  permanent  pulse  generator 
(RestoreUltra
TM, Medtronic Inc., Minneapolis, Minnesota, 
USA) was implanted into the subcutaneous space of the 
right lower quadrant of the abdomen. The patient’s chest 
pain decreased to 2 to 3 on the NRS, and he was satisfied 
with a treatment regimen of SCS and oral morphine 90 mg, 
gabapentin 1,800 mg, and nortriptyline 20 mg per day. SH Lee, et al / Spinal Cord Stimulation for Angina Pectoris 123
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Fig. 2. Chest radiographs 
showing an octad electrode. 
The tip of the electrode is 
located in the C7-T1 epidural
space, slightly left of the 
center. (A) Anteroposterior 
view. (B) Lateral view.
Although the d oses of medication did not decrease, the 
improvement in the patient’s clinical symptoms persisted 
at the follow-up evaluation performed 1 year after surgery. 
DISCUSSION
N o w a d a y s ,  m o s t  C A D  p a t i e n t s  c a n  b e  a d e q u a t e l y  
treated with revascularization and anti-anginal medications. 
However, some patients are still refractory to these treat-
m e n t s ,  o r  a r e  p o o r  c a n d i d a t e s  f o r  p e r c u t a n e o u s  i n t e r -
vention, surgical revascularization, or additional procedures 
[ 1 ] .  A  f e w  p a t i e n t s  w i t h  s i g n i f i c a n t  i n t e r m i t t e n t  a n g i n a  
demonstrate normal coronaries on angiography. The latter 
condition  is  referred  to  as  “microvascular  angina” o r  
“cardiac syndrome X,” and is characterized by typical ex-
ercise-triggered chest pain with ST-segment depression 
on exercise electrocardiogram [8]. Patients with refractory 
angina pose treatment dilemmas for the cardiac treatment 
team, and are not adequately treated. Treatment options 
that have emerged for refractory angina pectoris include 
thoracic epidural injection, stellate ganglion blockade, en-
hanced  external  counterpulsation,  percutaneous  my-
ocardial  laser  revascularization,  transcutaneous  electric 
nerve stimulation, and SCS [1,9].
Neuromodulation,  such  as  SCS,  can  be  defined  as 
electrical or chemical modification of the nervous system 
t h a t  c h a n ges  t h e a c t u a l  o r  p e r c e i v e d  n e u r o t r a ns m is si o n 
and response to a stimulus or condition. SCS is a minimally 
invasive technique in which electrodes are implanted in the 
epidural space to stimulate the dorsal columns of the spinal 
cord by passing an electric current. Since the late 1960s 
[10], SCS has been increasingly used in a variety of chronic 
neurogenic pain conditions, as understanding of the mech-
anisms  of  SCS  has  increased  and  its  techniques  and 
equipment have been refined [11-13].
Since the first report of SCS as a treatment for angina 
was published in 1987, a large number of subsequent clin-
ical trials and systematic reviews have demonstrated the 
clinical efficacy of SCS in angina pectoris in producing an 
anti-ischemic  effect,  symptomatic  relief,  and  improve-
ments in functional status and quality of life [4-6,14]. A 
recent meta-analysis revealed similar outcomes and lower 
healthcare costs with SCS as compared to coronary artery 
bypass  grafting  and  percutaneous  myocardial  laser  re-
vascularization for the treatment of refractory angina [7]. 
Thus, SCS has been recommended by American College of 
C a r d i o l o g y  a n d  A m e r i c a n  H e a r t  A s s o c i a t i o n  g u i d e l i n e s  
(c l a ss  I I b)  [ 15] , a n d  t h e  E u r o p ea n  S o c i e t y  o f C a r d i o l o gy 
Joint Study Group on the treatment of refractory angina 
(therapeutic alternative 1) [1].
The  basic  background  of  SCS  was  the  gate  control 
t h e o r y  t h a t  s t i m u l a t i o n  o f  A - b e t a  f i b e r s  m o d u l a t e s  t h e 
dorsal horn gate and therefore reduces the nociceptive in-
p u t  f r o m  t h e  p e r i p h e r y  [ 1 6 ] .  H o w e v e r ,  f u r t h e r  r e s e a r c h 
suggests that other mechanisms may play a more sig-
nificant role. Potential explanations for the anti-anginal 
and anti-ischemic effects of SCS include direct pain block-
ing, reduced oxygen consumption, decreased sympathetic 
tone, redistribution of myocardial blood flow from non-is-
chemic to ischemic areas, possible improved coronary mi-
crocirculatory blood flow, possible increase in beta-endor-
phin levels, and modulation of intracardiac neurons [14,17,18]. 124 Korean J Pain Vol. 25, No. 2, 2012
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ST segment monitoring has demonstrated a reduction in 
the total number and duration of ischemic episodes in SCS 
patients [19]. Nevertheless, SCS remains underused, possi-
bly due to its only partially understood mechanism of ac-
tion, as well as the rapid development of transluminal re-
vascularization procedures. The reluctance to employ SCS 
for refractory angina may also result from the fear that 
this technique would only treat pain without affecting is-
chemia,  thus  concealing  acute  myocardial  infarction. 
However, it has been reported that SCS does not mask the 
pain of myocardial ischemia as a warning signal for in-
farction [19,20].
In the case discussed here, although the patient had 
normal coronary arteries on CAG after revascularization, 
his angina was persistent and aggravated. Cardiologists 
decided that additional coronary intervention was not nec-
essary for reducing his angina. After the patient’s referral 
to the pain clinic, we tried various treatment options for 
refractory angina pectoris. However, none of the methods 
we tried prevented the progression of his pain. Finally, we 
recommended SCS to the patient. SCS did not completely 
eliminate his angina, but it successfully reduced his pain 
and medication requirements. 
In conclusion, patients with refractory angina pectoris 
s uf f e r  f r o m  se v e r e s y m p t o m s a n d  i m p a i r ed  a c t i vi t i e s o f 
daily living. Spinal cord stimulation could allow them to 
have reduced pain and improved quality of life. This case 
might provide the impetus for increased consideration of 
S C S  a s  a  t h e r a p e u t i c  m o d a l i t y  i n  t h i s  p a t i e n t  g r o u p  i n 
Korea.
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